supported by the National Natural Science Foundation of China(82072675,82273197,82173933);Fundamental Research Funds for the Central Universities(020814380160).
Background:As a novel blocker of vascular endothelial growth factor receptor(VEGFR),fruquintinib has been approved for treating colorectal cancer(CRC).However,its dosage and therapeutic efficacy are limited by its wid...
This article discusses the article written by Tan et al.Transarterial chemoembol-ization(TACE)is one of the main treatment methods for advanced hepatocellular carcinoma(HCC).There are other vascular interventional the...
In recent years,a lot of research has been done on silver nanoparticles(SNP)due to their numerous applications in the biomedical,pharmaceutical,and drug delivery industries.In this present study SNP were green synthes...
Lung cancer is the most prevalent and fatal cancer in China and even around the world, and many patients are found in the late stage of lung cancer. For the treatment of advanced lung cancer, in addition to traditiona...
grants from the National Science Foundation of China(Nos.82173125,81974374,82072664,82103677);Tianjin Key Medical Discipline(Specialty)Construction Project(TJYXZDXK-009A);The Science&Technology Development Fund of Tianjin Education Commission for Higher Education(2020KJ127).
Diferent from necrosis,apoptosis,autophagy and other forms of cell death,ferroptosis is a mechanism that catalyzes lipid peroxidation of polyunsaturated ftty acids under the action of iron divalent or lipoxygenase,lea...
supported by the National Natural Science Foundation of China(Grant No.82272744);Natural Science Foundation of Guangdong Province(Grant No.2022A1515010814);Sun Yat-sen University Clinical Research 5010 Program(Grant No.2022008).
Objective:Glioblastomas are highly vascularized malignant tumors.We determined the efficacy and safety of the anti-angiogenic multi-kinase inhibitor,anlotinib,for a newly diagnosed glioblastoma.Methods:This multicente...
supported by Guangdong Basic and Applied Basic Research Foundation(2023A1515010969);Natural Science Foundation of Top Talent of SZTU(GDRC202305).
Anti-tumor angiogenesis therapy, targeting the suppression of blood vessel growth in tumors, presents a potent approach in the battle against cancer. Traditional therapies have primarily concentrated on single-target ...
Background:Small cell lung cancer(SCLC)is an aggressive malignant tumor with strong immunosuppressive effects,characterized by rapid doubling time and poor prognosis.Currently,effective therapeutic options are urgentl...
Supported by Natural Science Foundation of Guangdong Province,No.2020A1515011539.
BACKGROUND Hepatic arterial infusion chemotherapy(HAIC)has been proven to be an ideal choice for treating unresectable hepatocellular carcinoma(uHCC).HAIC-based treatment showed great potential for treating uHCC.Howev...
Diabetic retinopathy(DR)is a prevalent microvascular complication of diabetes and the leading cause of blindness and severe visual impairment in adults.The high levels of glucose trigger multiple intracellular oxidati...